For citations:
Kulikov A.Yu., Makarova E.I., Avdeev S.N., Aisanov Z.R., Arkhipov V.V., Emel'yanov A.V., Il'ina N.I., Kurbacheva O.M., Matveev N.V., Nenasheva N.M., Fedosenko S.V. Pharmacoeconomic analysis of therapy with reslizumab in severe eosinophilic asthma. PULMONOLOGIYA. 2018;28(1):50-60. (In Russ.) https://doi.org/10.18093/0869-0189-2018-28-1-50-60